MIR5092

Across TCGA pan-cancer cohorts, MIR5092 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR5092’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR5092 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR5092 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

KIRC, LUSC, and STAD are the cancer types where MIR5092 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR5092 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.254	.014	4	view →
LUSC	All	All	−0.184	.008	2	view →
STAD	Male	All	+0.138	.044	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR5092–KIRC

Open the KIRC breakdown →